Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Kuros announces final result of Capital Increase – total gross proceeds of CHF 12.5 million raised
Kuros announces results of Rights Offering
Kuros provides an update on the Capital Increase
Extraordinary General Meeting of Kuros Biosciences approves all resolutions
Kuros announces the terms of the proposed capital increase through a discounted rights offering expected to raise up to CHF 12 million gross proceeds for the commercialization of its products and the further development of its product candidates
Kuros convenes Extraordinary General Meeting